A Chinese Prescription Chuanxiong Chatiao San for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abstract

Backgrounds. Chuanxiong Chatiao san (CXCT) is a famous Chinese classical prescription. It has a favorable effect in treating migraine. It is reported that CXCT combined with Western conventional medicine (WCM) could increase the therapeutic efficacy on migraine. The purpose of this paper is to systematically assess the clinical efficacy, safety, and some indexes of CXCT for migraine. Methods. PubMed, Embase Database, China National Knowledge Infrastructure (CNKI), Wanfang Database, the Cochrane Library, and the CBM were searched from January 2000 to February 2019. We made a detailed record of outcome measurements. Meta-analysis was performed using RevMan 5.3 software. Results. A total of 3307 patients were included in the 37 articles. Meta-analysis showed that CXCT significantly increased the total efficiency rate (TER), compared with Western medicine treatment (WMC) (P < 0.00001). When CXCT is combined with WMC, the result showed that P < 0.00001. CXCT was significantly reduced the adverse events (AEs) compared with WMC (P < 0.00001). The levels of VAS, number of migraine episodes (NE), and time of headache duration (TD) were significantly reduced (P < 0.00001). Platelet function and blood rheology level were improved via a significantly decrease in 5-HT and β-EP (P < 0.00001). Other indicators such as substance P, CGRP high-cut viscosity, low-cut viscosity, plasma viscosity, and fibrinogen were significantly reduced (P < 0.00001). Conclusion. Our findings provide evidence that CXCT and CXCT combined with WMC have higher efficacy in the treatment of migraine compared with WCM alone. Methodological quality was generally low, so the conclusion of this paper has some limitations and it has to be carefully evaluated.

Efficacy and Safety of Oral Chinese Herbal Medicine for Migraine: A Systematic Review and Meta-Analyses Using Robust Variance Estimation Model

“…In China, over 60% of migraine patients seek Chinese medicine therapies, including Chinese herbal medicine (CHM), for migraine management (12). Research evidence demonstrated that oral CHM was comparable with or superior to conventional pharmacotherapies including flunarizine (13)(14)(15), and produced significant add-on effects when it was used in combination with conventional pharmacotherapies for migraine (13,16). Two systematic reviews concluded that oral CHM was more efficacious than placebo as prophylactic management for migraine (15,17).…”

Herbal treatments for migraine: A systematic review of randomised‐controlled studies

“…Positive effects from multicombination formulas have been identified in several studies. For example, in two meta‐analyses, Chuanxiong, a Chinese medicine combination, was reported to effectively treat migraine in adults (Shan et al, 2018; Wang et al, 2019). In several studies, positive acute and prophylactic effects from a Gingko Biloba preparation containing several nutrients (e.g., CoQ10, magnesium, and vitamin B2) (Allais, D'Andrea, Maggio, & Benedetto, 2013; D'Andrea et al, 2009; Esposito & Carotenuto, 2011; Esposito, Ruberto, Pascotto, & Carotenuto, 2012; Usai, Grazzi, & Bussone, 2011) were also identified.…”

Understanding Traditional Chinese Medicine Therapeutics: An Overview of the Basics and Clinical Applications

“…Wang et al (2019) conducted a systematic review and meta-analysis of high-quality RCTs using Chinese formulas, including “Danshen” for cancer treatment. These authors found that the “Danshen” formulae combined with chemotherapy for cancer treatment were better than a conventional drug treatment plan alone [ 56 ]. Indeed, radix Salviae Miltiorrhizae (“Danshen”) has been used in clinical practice for over 2000 years.…”